4//SEC Filing
Spiess Bernhard E. 4
Accession 0001447362-21-000130
CIK 0001447362other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:06 PM ET
Size
8.5 KB
Accession
0001447362-21-000130
Insider Transaction Report
Form 4
Spiess Bernhard E.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-08$1.92/sh+8,989$17,259→ 22,551 total - Sale
Common Stock
2021-06-08$70.00/sh−8,989$629,230→ 13,562 total - Exercise/Conversion
Stock option (right to buy)
2021-06-08−8,989→ 14,878 totalExercise: $1.92Exp: 2026-05-23→ Common Stock (8,989 underlying)
Footnotes (3)
- [F1]These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 24, 2021.
- [F2]Includes 1,815 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan.
- [F3]25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
Related Parties
1- filerCIK 0001782994
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:06 PM ET
- Size
- 8.5 KB